drugset / Trial / NCT00145717

China Plant Sterol Trial

NCT00145717 ↗

Phase 3 Completed 300 enrolled The George Institute Peking University · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this study is to see if plant sterols are effective at lowering blood cholesterol levels in Chinese people. The study will be done with Chinese colleagues based at Peking University in Beijing with whom our Institute has a well-established collaboration. The study will be randomised, placebo-controlled and double-blind. The total study period for participants will be an average of seven weeks comprised of a two-week placebo run-in period and a five-week follow-up on randomised treatment. Randomised treatment will comprise either placebo, low- or standard-dose plant sterol. The primary outcome for the study will be blood cholesterol levels.

Timeline

Start
2005-04
Primary completion
—
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Plant Sterol Unknown 1.5 g Oral
Subject Plant Sterol Unknown 2.3 g Oral